证券记录 · 已归档季度
LLY
Eli Lilly and Company · Healthcare · Drug Manufacturers - General
22被追踪持有人
n/aΔ持有人
112.43M持有股份
$101.75B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 191 | +4 | 666.78M | $798.87B | +6 | −3 |
| Q1 2026 | 191 | -3 | 666.59M | $613.20B | +1 | −5 |
| Q4 2025 | 193 | +2 | 707.04M | $758.81B | +3 | n/a |
| Q3 2025 | 27 | -3 | 329.88M | $251.63B | +2 | −6 |
| Q2 2025 | 28 | -1 | 307.45M | $239.60B | +2 | −3 |
| Q1 2025 | 26 | 0 | 140.32M | $115.83B | +1 | −1 |
| Q4 2024 | 26 | +1 | 145.00M | $111.91B | +3 | −2 |
| Q3 2024 | 24 | +2 | 109.89M | $97.29B | +2 | n/a |
| Q2 2024 | 22 | n/a | 112.43M | $101.75B | n/a | n/a |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 21.81M | n/a | $19.75B | 3.2% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 20.65M | n/a | $18.70B | 2.2% | n/c | 1 | SEC ↗ ×2 |
| 3 | PRIMECAP Management ✦ | 19.62M | n/a | $17.76B | 12.9% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 17.01M | n/a | $15.35B | 1.3% | n/c | 1 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (被动) | 11.00M | n/a | $9.96B | 1.5% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 10.78M | n/a | $9.76B | 1.7% | n/c | 1 | SEC ↗ ×9 |
| 7 | Fisher Asset Management ✦ | 4.89M | n/a | $4.43B | 1.9% | n/c | 1 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 1.61M | n/a | $1.46B | 1.3% | n/c | 1 | SEC ↗ |
| 9 | Tiger Global Management ✦ | 930.00K | n/a | $842.00M | 3.9% | n/c | 1 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 827.68K | n/a | $749.37M | 1.4% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 789.56K | n/a | $714.85M | 1.0% | n/c | 1 | SEC ↗ ×3 |
| 12 | Millennium Management ✦ | 532.04K | n/a | $481.70M | 0.4% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 500.83K | n/a | $453.45M | 0.5% | n/c | 1 | SEC ↗ ×2 |
| 14 | AQR Capital Management ✦ | 474.55K | n/a | $429.65M | 0.7% | n/c | 1 | SEC ↗ ×5 |
| 15 | D. E. Shaw & Co. ✦ | 237.22K | n/a | $214.78M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 16 | Two Sigma Investments ✦ | 225.78K | n/a | $204.42M | 0.5% | n/c | 1 | SEC ↗ |
| 17 | Coatue Management ✦ | 207.05K | n/a | $187.46M | 0.7% | n/c | 1 | SEC ↗ ×4 |
| 18 | Viking Global Investors ✦ | 144.18K | n/a | $130.53M | 0.5% | n/c | 1 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 95.74K | n/a | $86.68M | 0.5% | n/c | 1 | SEC ↗ |
| 20 | Dodge & Cox ✦ | 45.98K | n/a | $41.63M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | GAMCO Investors ✦ | 35.83K | n/a | $32.44M | 0.4% | n/c | 1 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 11.95K | n/a | $10.82M | 0.1% | n/c | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 4,323 持有人, 762.84M 股份, $674.93B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 17
Jonsson Patrik
Officer · 6.50K 股 · $7.64M
Aug 10
Zakrowski Donald A
Officer · 2.00K 股 · $2.37M
Aug 07
Hakim Anat
Officer · 5.00K 股 · $5.95M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 23
SC 13G/A: LILLY ENDOWMENT INC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据